Top Markets
Coin of the day
Pharmaron Beijing Co., Ltd. Pharmaron Beijing Co., Ltd.

Pharmaron Beijing Co., Ltd.

300759
주식 순위 #2166
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a... Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antimicrobial agents, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science and preformulation, formulation development, and analytical development. It also provides clinical research services; macromolecular and cell and gene therapy services comprising drug discovery, development and production services, cell and gene therapy laboratory services, and gene therapy drug development and production services. In addition, the company is involved in the provision of technology development, technology transfer, technical consultation, technical services, and technical training; import and export of goods and technologies. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
주가
$6.73
시가총액
$9.94B
변동 (1일)
3.48%
변동 (1년)
51.19%
국가
CN
거래 Pharmaron Beijing Co., Ltd. (300759)

카테고리

Pharmaron Beijing Co., Ltd. (300759)의 주식 분할 이력
Pharmaron Beijing Co., Ltd. 주식 (심볼: 300759)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 25, 2026에 발생했습니다.
Aug 25, 2026 이전에 매수한 300759 주식 1주는 현재 0주의 300759 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH